Your browser doesn't support javascript.
loading
Montrer: 20 | 50 | 100
Résultats 1 - 1 de 1
Filtrer
Plus de filtres










Base de données
Gamme d'année
1.
J Control Release ; 97(1): 101-13, 2004 May 31.
Article de Anglais | MEDLINE | ID: mdl-15147808

RÉSUMÉ

The novel nanoparticles (CPT-NP) were prepared by the solvent evaporation method using methoxypolyethylene glycol-poly(DL-lactic acid) block copolymer as a matrix and camptothecin (CPT) as an antitumor agent, and the antitumor characteristics were examined in vitro and in vivo. The mean diameter of CPT-NP was approximately 250 nm. The drug release from CPT-NP in phosphate-buffered saline, pH 7.4, depended on the particle concentration; in the diluted condition, the initial rapid release was greater and subsequent gradual release was faster. After i.v. administration (0.5 mg CPT eq./kg) in rats, CPT-NP showed a longer plasma retention than CPT solution. In both single (2.5 mg CPT eq./kg) and double (2.5 mg CPT eq./kg x 2) administration to mice bearing sarcoma 180 solid tumor, CPT-NP were much more effective than CPT solution; especially, the tumor disappeared completely in three of the four mice in twice administration of CPT-NP, when the body weight did not decrease markedly. After i.v. administration to the tumor-bearing mice, CPT-NP showed better plasma retention, and high and long tumor localization. CPT-NP are suggested to greatly improve the efficacy of CPT due to their pharmacokinetic features.


Sujet(s)
Antinéoplasiques/pharmacocinétique , Camptothécine/pharmacocinétique , Acide lactique/pharmacocinétique , Nanostructures , Polyéthylène glycols/pharmacocinétique , Animaux , Antinéoplasiques/usage thérapeutique , Camptothécine/usage thérapeutique , Acide lactique/usage thérapeutique , Mâle , Souris , Polyéthylène glycols/usage thérapeutique , Rats , Rat Wistar , Sarcome 180 de Crocker/traitement médicamenteux , Sarcome 180 de Crocker/métabolisme
SÉLECTION CITATIONS
DÉTAIL DE RECHERCHE